Tag: Ikoniscope20
Ikonisys Announces Installation of Ikoniscope20 Solution at Leading U.S. Urology Lab
By Claude Leguilloux Published on 09/26/2022 at 6:10 p.m. Photo credit © Reuters …
Ikonisys announces that it has entered into a partnership with BioVendor Laboratory Medicine for the distribution of the Ikoniscope20 system in Eastern Europe – 09/13/2022 at 17:45
Paris, September 13, 2022 – 5:45 p.m. – Ikonisys SA (ISIN Code: FR00140048X2 / Mnemonic: ALIKO), a company specializing in the early and precise detection of cancer with a unique…
Ikonisys announces the first sale of its Ikoniscope20 solution including the newly added reagents, to Comprehensive Urology – 06/22/2022 at 18:00
First sale of complete solution validates Ikonisys business model and paves the way for accelerated business development Paris, June 22, 2022 – 6 p.m. CEST – Ikonisys SA (ISIN Code:…
Ikonisys and Evosciences Leasing support the commercial expansion in Europe and the United States of Ikoniscope20 – 05/12/2022 at 18:30
To receive all of Ikonisys’ financial information in real time, send a request by email to [email protected]. Your registration will be immediate. “Based on the successful commercial development of our…
The quality of the preliminary results of the Ikoniscope20 obtained with the UConn School of Medicine in the detection of rare cells emerges above the reference standards in immuno-oncology – 02/16/2022 at 18:40
To receive all of Ikonisys’ financial information in real time, send a request by email to [email protected]. Your registration will be immediate. • The Ikoniscope20 performs immune monitoring functions in…
Ikonisys announces the successful installation of the Ikoniscope20 at Tomalab, one of the largest genetic laboratories in Italy – 02/07/2022 at 19:00
To receive all of Ikonisys’ financial information in real time, send a request by email to [email protected]. Your registration will be immediate. The Ikoniscope20 has been successfully installed at Toma…